| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |